FindAir
FindAir is a Kraków-based med-tech company developing smart inhaler sensors, AI-powered inhalation training devices, and connected drug delivery technology for asthma and COPD patients, serving healthcare providers, pharmaceutical companies, clinical researchers, and medical device distributors across Europe and the US.
- Company typePrivate
- Founded2016
- HeadquartersKraków, Poland
- Headcount11–50
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What FindAir does
FindAir (FindAir Sp. z o.o.) is a Kraków, Poland-based med-tech company founded in 2016 that develops smart inhaler technology and software for asthma and COPD management. Its product portfolio comprises three device families: FindAir ONE add-on sensors compatible with seven inhaler types (pMDI, Ellipta, Turbuhaler, Diskus, Easyhaler, Nexthaler, Rapihaler); Smarthaler Trainer (Home and Station) devices for AI-powered inhalation technique training; and Smarthaler Drug Delivery for pharmaceutical OEM and modular integration. The software stack includes mobile apps (FindAir Asthma Diary, FindAir Research App, FindAir Smarthaler App), web platforms (Doctor's Platform, Research Platform), an API and SDK for third-party integration, and AsthmaAI, a branded AI module for asthma and COPD exacerbation prediction. The company operates under ISO 13485, CE, FCC, and GDPR certifications.
FindAir generates revenue through five streams: hardware sales of FindAir ONE add-ons and Smarthaler devices via its own e-commerce store; subscription/recurring revenue from software platforms and apps; licensing and OEM/white-label partnerships with pharmaceutical companies for custom smart inhaler development; SDK and API integration services for healthcare platforms, EHRs, and research systems; and channel sales through medical device distributors. Pricing is quote-based with multi-year contracts and no public price list. Go-to-market is sales-led, combining direct enterprise outreach, industry events (TechCrunch Disrupt, Arab Health), content marketing, and distributor partnerships. Customer segments include remote patient monitoring services, pharmaceutical and drug delivery companies, health clinics and medical institutions, research and clinical trial sponsors, and medical device distributors, with named relationships including AstraZeneca, Aptar, University Health Network, Radboud UMC, UF Health, Asthma UK, University of Leicester, and RespoGene. The company operates from Poland with commercial activity across Germany, France, Portugal, and a stated US expansion initiative backed by a $1.9M seed round closed in June 2023.
FindAir firmographics
Firmographics- Name
- FindAir
- Legal name
- Findair Sp. z o. o.
- Website
- https://findair.eu
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- FindAir is a Kraków-based med-tech company developing smart inhaler sensors, AI-powered inhalation training devices, and connected drug delivery technology for asthma and COPD patients, serving healthcare providers, pharmaceutical companies, clinical researchers, and medical device distributors across Europe and the US.
- Ownership category
- akta.pro rank
FindAir industry classification
Industry- Product category
- Smart Inhaler Technology and Respiratory Care Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers) (HLACAPAH)
- akta.pro secondary industries
- Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps) (HLAHAIAM), Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL), Asthma & Allergy-Related Pulmonary Care (HLAKANAD)
Keywords
Where FindAir is headquartered
LocationHeadquarters
- HQ city
- Kraków
- HQ country
- Poland
- HQ region
- Europe
Offices1 record
Markets served
FindAir business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Smart Inhaler Hardware Sales: Sale of FindAir ONE add-on sensors that attach to existing inhalers for medication monitoring. Devices are sold directly through the company store and via distributors.
- Smarthaler Device Sales: Sale of Smarthaler Trainer devices (Home and Station versions) for inhalation technique training, both for personal/home use and professional clinical settings.
- Software Platform & Apps: Mobile apps (FindAir Asthma Diary, FindAir Research App, FindAir Smarthaler App) and web platforms (Doctor's Web Platform, Research Web Platform) with associated data monitoring and analytics capabilities.
- Pharma OEM/White-label Partnerships: Custom smart inhaler development partnerships with pharmaceutical companies to integrate Smarthaler technology into their drug delivery devices, including complete design history files and regulatory support.
- SDK & API Integration Services: Developer integration services enabling healthcare platforms, EHRs, and research systems to connect with FindAir devices through APIs and SDKs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based pricing for all products |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels5 records
FindAir product offering
Product offeringCore offering
FindAir designs and manufactures smart inhaler add-on sensors (FindAir ONE) that attach to existing inhaler types (pMDI, Ellipta, Turbuhaler, Diskus, Easyhaler, Nexthaler, Rapihaler) to automatically log medication usage. The company also produces the Smarthaler Trainer (Home and Station variants) for AI-powered inhalation technique training, and offers Smarthaler Drug Delivery technology for pharmaceutical partners to integrate connected monitoring into their inhaler devices. These hardware products are complemented by mobile apps, web platforms for clinicians and researchers, and the AsthmaAI predictive analytics system.
Product overview
FindAir provides a comprehensive ecosystem of smart respiratory devices and software for asthma and COPD management. The portfolio consists of three core device families: (1) FindAir ONE add-on sensors that attach to existing inhalers (pMDI, Ellipta, Turbuhaler, Diskus, Easyhaler, Nexthaler, Rapihaler) for automatic usage tracking; (2) Smarthaler Trainer for personal and professional use providing AI-powered inhalation technique analysis and training; and (3) Smarthaler Drug Delivery for pharmaceutical partners as integrated or modular connected inhaler technology. These devices connect through a software ecosystem comprising mobile apps (FindAir Asthma Diary, Research App, Smarthaler App) and web platforms (Doctor's Web Platform, Research Platform) that enable real-time patient monitoring, clinical decision support, and research data collection. The FindAir API and SDK enable third-party integration, while AsthmaAI provides AI-powered exacerbation predictions.
Differentiator
Problem solved
Functional benefit
Brands
- FindAir ONE: Smart inhaler add-on sensors that attach to existing inhalers for medication intake monitoring and adherence tracking
- Smarthaler
- AsthmaAI
- FindAir Asthma Diary
- Smarthaler Trainer
- FindAir Research Platform
Products and services
- FindAir ONE Smart Inhaler Add-ons A family of inhaler add-on sensors that attach to existing inhalers (pMDI, Ellipta, Turbuhaler, Diskus, Easyhaler, Nexthaler, Rapihaler) to enable remote monitoring of medication intake, automatically logging every usage with timestamp, date, location, and adherence data for asthma and COPD patients and their care teams.
- Smarthaler Trainer Home A consumer-facing device for independent inhalation technique training at home, featuring an interactive learning system with AI-powered real-time flow analysis to help patients measure, correct, and educate about proper inhalation technique.
- Smarthaler Trainer Station
Quantifiable outcome
- 180% increase in medication adherence compared to traditional reporting methods
- +6 more outcomes
Companies that use FindAir
Customer profileNamed customers7 records
Segments5 records
Ideal customer profiles5 records
FindAir technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability4 records
Feature6 records
FindAir partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- AptarcoreAptar logo appears in trusted-by section, indicating collaboration in connected drug delivery solutions. Aptar is a leading global provider of drug delivery systems.
- AstraZenecacoreAstraZeneca logo appears in trusted-by section, indicating collaboration in respiratory care and connected inhaler solutions for asthma and COPD treatment.
Scale indicators5 records
Recent moves6 records
Expansion highlights8 records
FindAir competitors and assessment
Company assessmentEmerging players
- Huma Therapeutics: Digital health platform focused on remote patient monitoring across multiple conditions, including respiratory. Comparable as a SaaS RPM partner that could integrate with FindAir sensors via the SDK/API, but also a potential adjacent competitor for RPM contracts.
Broad incumbents
- AstraZeneca: Global pharma with leading respiratory franchises (Symbicort, Breztri, Trixeo, Fasenra) and an active connected-device strategy. AstraZeneca is both a FindAir customer/partner and a potential competitor as it expands its own digital inhaler capabilities.
- ResMed: Parent company of Propeller Health and a major player in connected respiratory/sleep health. Provides the distribution scale, capital, and clinical evidence engine behind Propeller, the most direct competitive threat to FindAir.
- GSK (GlaxoSmithKline): Major respiratory pharma (Trelegy Ellipta, Advair Diskus, Ventolin) actively investing in sensor-enabled Ellipta inhalers. A key OEM partner candidate for FindAir Smarthaler Drug Delivery and a competitor to the add-on business if Ellipta goes fully connected.
- Chiesi: Respiratory-focused pharma (Fostair, Trimbow, Nexthaler) with growing digital health initiatives. FindAir explicitly offers a Nexthaler add-on, making Chiesi both a near-term distribution target and a long-term OEM partner candidate.
- Teva Pharmaceutical Industries (Digihaler): Pharma major with the Digihaler line of FDA-approved digital inhalers (ProAir Digihaler, AirDuo Digihaler, ArmonAir Digihaler) featuring built-in sensors and companion apps. Competes with FindAir at the integrated-inhaler level and represents both a potential OEM partner and a threat to the add-on model.
Direct peers
- Propeller Health (ResMed): The market-leading smart inhaler attachment company, now owned by ResMed, offering Bluetooth sensors and a companion app for medication adherence in asthma and COPD. Most directly comparable to FindAir's FindAir ONE add-on business, with broader commercial scale and deeper pharma partnerships.
- Cohero Health: US-based connected respiratory health company offering Bluetooth spirometers and smart inhaler sensors with a patient and clinician platform. Comparable in combining hardware sensors with software analytics for asthma and COPD management.
- Adherium: Listed (ASX/OTC) connected respiratory health company selling Hailie smart inhaler sensors for multiple inhaler formats (similar to FindAir ONE) plus a clinician portal. Direct competitor in the connected-inhaler add-on category with an FDA-cleared footprint and US commercialization history.
Others
- Aptar Pharma: Global leader in drug delivery devices and dispensing systems for respiratory, injectable, and eye care. Listed as a FindAir trusted partner and a logical OEM collaborator for embedding Smarthaler technology into actuators, while also being a potential competitor through internal connected-device programs.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
FindAir social profiles
Digital presenceFindAir compliance and trust
Trust signalCompliance4 records
FindAir financial estimates
Financial estimateRevenue estimate
Valuation estimate
FindAir leadership team
Management profileNumber of profiles
Profiles3 records
FindAir funding detail
Funding detailFunding overview
Funding rounds4 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FindAir M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FindAir
What does FindAir do?
FindAir designs and manufactures smart inhaler add-on sensors (FindAir ONE) that attach to existing inhaler types (pMDI, Ellipta, Turbuhaler, Diskus, Easyhaler, Nexthaler, Rapihaler) to automatically log medication usage. The company also produces the Smarthaler Trainer (Home and Station variants) for AI-powered inhalation technique training, and offers Smarthaler Drug Delivery technology for pharmaceutical partners to integrate connected monitoring into their inhaler devices. These hardware products are complemented by mobile apps, web platforms for clinicians and researchers, and the AsthmaAI predictive analytics system.
Is FindAir a public or private company?
FindAir is a private company. It is classified as venture growth investor backed and is currently operating.
When was FindAir founded?
FindAir was founded in 2016. It employs 11 to 50 people.
Where is FindAir based?
FindAir is headquartered in Kraków, Poland, in the Europe region.
How does FindAir make money?
Five revenue lines are on record. Smart Inhaler Hardware Sales are the primary driver. The others are smarthaler Device Sales, software Platform & Apps, pharma OEM/White-label Partnerships and SDK & API Integration Services.
Who are FindAir's main competitors?
Huma Therapeutics is listed as an emerging player. Broad incumbents are AstraZeneca, ResMed, GSK (GlaxoSmithKline), Chiesi and Teva Pharmaceutical Industries (Digihaler). Direct peers are Propeller Health (ResMed), Cohero Health and Adherium. Aptar Pharma is listed as an others.
Does FindAir have an API?
Yes. FindAir API enables seamless connection between systems and all FindAir devices, providing quick access to accurate medication usage and inhalation data. Designed with security and compliance in mind, the API ensures reliable data transfer while offering comprehensive developer documentation. Supports integration with clinical platforms, research tools, and patient management systems.
What industry is FindAir in?
FindAir's product category is Smart Inhaler Technology and Respiratory Care Devices. Its primary akta.pro industry code is HLACAPAH, Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers), with a secondary code of HLAHAIAM, Drug Delivery Connectivity, Sensors & Digital Add-Ons (Smart Caps/Companion Apps). Its NAICS code is 339112 and its SIC code is 3841.